Consistent with the previous results, the application of the P2X7R antagonist A-804598 also alleviated disease progression in late pre-onset ALS by blocking the phagocytotic activity of SOD-1-G93A mouse microglia [126]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.